Abstract:Circulation: Heart Failure, Ahead of Print. BACKGROUND:In October 2018, the US heart transplant (HT) allocation system was revised giving patients with left ventricular assist device (LVAD) intermediate priority status. Few studies have examined the impact of this policy change on outcomes among patients with LVAD. We sought to determine how the allocation change impacted waitlist and posttransplant mortality in patients with LVAD.METHODS:We retrospectively assessed the United Network for Organ Sharing registry for patients with LVAD who were listed for or underwent HT between October 2016 and October 2021. We evaluated waitlist mortality using competing risks analysis and a multivariable Fine-Gray model, and posttransplant mortality using Kaplan-Meier survival analysis and a multivariate proportional hazards model.RESULTS:We analyzed data from 3835 patients with LVAD listed for HT and 3486 patients with LVAD who underwent HT during the study period. Listing for HT preallocation change was significantly associated with an increased risk of waitlist mortality (GrayP=0.0058) compared with postallocation change. After adjustment for covariates, mortality differences by listing era were attenuated, but LVAD brand was significantly associated with waitlist mortality (HM3 versus HMII; hazard ratio, 0.38 [95% CI, 0.21–0.69];P=0.002; HVAD versus HMII; hazard ratio, 0.79 [95% CI, 0.48–1.30];P=0.36; overallP=0.004).In contrast, HT postallocation change was associated with increased posttransplant mortality (log-rankP=0.0172) compared with preallocation change. In a multivariable analysis, the association with posttransplant mortality between transplant eras was attenuated, but ischemic time (hazard ratio, 1.16 [95% CI, 1.07–1.26];P<0.001) and status at time of HT (Status 1–3 versus 4; hazard ratio, 1.29 [95% CI, 1.04–1.61];P=0.02) were significantly associated with posttransplant mortality.CONCLUSIONS:Among patients with LVAD, lower waitlist mortality postallocation change was likely driven by improved LVAD technology. Higher posttransplant mortality following the allocation change was largely attributable to longer ischemic times and patient acuity.

Effect of transplant center experience on post-transplant mortality for patients supported with an implantable left ventricular assist device: an analysis of the united network for organ sharing (UNOS) thoracic registry

Ovicidal effect of some insecticides on the diamondback moth, Plutella xylostella (L.) (Lepidoptera: Yponomeutidae)

Three-Year Left Ventricular Assist Device Outcomes and Strategy After Heart Transplant Allocation Score Change

The Association Between Pulmonary Vascular Resistance and Posttransplant Outcomes Differs by Left Ventricular Assist Device Status

Contractile protein preparations from frozen rabbit muscle.

Impact of Heart Transplant Allocation Change on Waitlist Mortality and Posttransplant Mortality in Patients With Left Ventricular Assist Devices

Comparison of waitlist and post‐transplant outcomes in patients supported with total artificial heart versus continuous biventricular assist devices

Impact of ventricular assist device use on pediatric heart transplant waitlist mortality: Analysis of the scientific registry of transplant recipients database

Early outcomes in heart transplantation using donation after circulatory death donors in patients bridged with durable left ventricular assist devices

[Clinical treatment of MST-16 (Sobuzoxane) for malignant lymphoma].

Survival does not differ by annual center transplant volume—A Pediatric Heart Transplant Society Registry study

Impact of Patient Distance From Ventricular Assist Device–Implanting Center on Short- and Long-Term Outcomes

The Long-Term Survival of LVAD Patients—A TriNetX Database Analysis

"Durable Left Ventricular Assist Devices as a Bridge to Transplantation in The Old and The New World"

Association between caseload volume and outcomes in left ventricular assist device implantations - a EUROMACS analysis

Relationship between donor ejection fraction, left ventricular wall thickness and mortality in heart transplants recipients

Propensity matched post-transplant survival in durable CF-axial pump BTT patients with and without diabetes: A UNOS database analysis

Promoter recognition by Escherichia coli RNA polymerase. Effects of substitutions in the spacer DNA separating the -10 and -35 regions.

Reversibility of Precapillary Pulmonary Hypertension and Outcomes After Heart Transplantation Bridged with Left Ventricular Assist Devices: Insight from the UNOS

Outcomes Of Donor Circulatory Death Heart Transplantation In Recipients With Durable Left Ventricular Assist Device

Comparison of Intraoperative Blood Product Use During Heart Transplantation in Patients Bridged with Impella 5.5 versus Durable Left Ventricular Assist Devices